Ketamine-Like Depression Drug Isn’t a Surefire Hit

9:37am PST - March 6th, 2019    ketamine - Bloomberg

J&J’s Spravato is the biggest advance in years, but it may be tough for the drugmaker to turn it into a major moneymaker.